UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER
kmUU300MXic
kmUU300MXic
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Presentations<br />
Impact of primary (1º) tumor location on overall survival (OS) and<br />
progression-free survival (PFS) in patients (pts) with metastatic<br />
colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).<br />
Authors*: Alan P. Venook, Donna Niedzwiecki, Federico Innocenti, Briant Fruth, Claire Greene, Bert H.<br />
O’Neil, James Edward Shaw, James Norman Atkins, Laura E. Horvath, Blase N. Polite, Jeffrey A. Meyerhardt,<br />
Eileen Mary O’Reilly, Richard M. Goldberg, Howard S. Hochster, Charles David Blanke, Richard L. Schilsky,<br />
Robert J. Mayer, Monica M. Bertagnolli, Heinz-Josef Lenz<br />
Abstract #: 3504<br />
Presentation Date/Time: Sunday, June 5: 8:00 - 11:00 AM<br />
Location: Hall B1<br />
Session: Gastrointestinal (Colorectal) Cancer<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 3504)<br />
Venook Research Interests: Dr. Alan Venook is a nationally renowned expert in colorectal and liver cancers at<br />
the <strong>UCSF</strong> Helen Diller Family Comprehensive Cancer Center. He is highly regarded for his expertise in the<br />
effective use of the newest approaches and therapies to the treatment of colorectal cancer, as well treating<br />
primary and metastatic tumors to the liver. Dr. Venook has chaired and/or authored six major studies within<br />
the cooperative groups and he now Chairs the GI Committee of the Alliance for Clinical Trials in Oncology<br />
(formerly CALGB.)<br />
http://cancer.ucsf.edu/people/profiles/venook_alan.3698<br />
__________________________________________________________________________<br />
The relationship between primary tumor sidedness and prognosis in<br />
colorectal cancer.<br />
Authors*: Deborah Schrag, Shicheng Weng, Gabriel Brooks, Jeffrey A. Meyerhardt, Alan P. Venook<br />
Abstract #: 3505<br />
Presentation Date/Time: Sunday, June 5: 8:00 - 11:00 AM<br />
Location: Hall B1<br />
Session: Gastrointestinal (Colorectal) Cancer<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 3505)<br />
Venook Research Interests: Dr. Alan Venook is a nationally renowned expert in colorectal and liver cancers at<br />
the <strong>UCSF</strong> Helen Diller Family Comprehensive Cancer Center. He is highly regarded for his expertise in the<br />
effective use of the newest approaches and therapies to the treatment of colorectal cancer, as well treating<br />
primary and metastatic tumors to the liver. Dr. Venook has chaired and/or authored six major studies within<br />
the cooperative groups and he now Chairs the GI Committee of the Alliance for Clinical Trials in Oncology<br />
(formerly CALGB.)<br />
http://cancer.ucsf.edu/people/profiles/venook_alan.3698<br />
*<strong>UCSF</strong> authors in bold<br />
44